What We Do
RxAnte offers an integrated analytics platform that targets, manages, and evaluates medication quality programs. The RxAnte System delivers proactive, patient-level intervention recommendations to enable population-level improvements. Our technology can improve the effectiveness and efficiency of any medication use improvement program.
Our patent-pending analytics platform uses readily available claims and clinical data in a continuous learning and improvement process.
Who We Help
RxAnte’s leading technology helps:
Health Plans and Pharmacy Benefit Managers increase their adherence-related quality scores (e.g., Medicare Star Ratings, HEDIS measures).
Providers to more effectively manage the outcomes for patient populations for which they are accountable and better align workflow capabilities with the needs of each individual patient.
Care Management Organizations and companies delivering adherence interventions to enhance the outcomes and ROI of their programs by targeting and tailoring interventions to the patients most likely to benefit.
Pharmaceutical Companies to improve the efficacy and effectiveness of their drug therapy management programs delivered at scale.
RxAnte uses client data to assess individuals’ risk of different medication outcomes, identifies the most effective strategy to create the largest possible clinical and financial benefits, and equips each member of the care team with the right information to meet patients’ unique needs.
This analytic platform supports a suite of interactive data products for a comprehensive solution that enables what works best for each patient.
RxForecast accurately forecasts future medication use at a population level and identifies gaps in your organization’s intervention strategy relative to performance goals and intervention programs.
Better Decision Making
A large national PBM with millions of lives uses RxForecast to understand its likely future performance on key medication adherence (or medication “underuse”) measures and to inform its intervention strategy on behalf of its plan customers. At the end of the year, RxAnte’s plan-level forecasts had consistently and accurately predicted future performance for multiple therapy areas across dozens of individual health plan contracts. As a result, the client could make better investment decisions about how to allocate resources to most efficiently achieve population-level goals on key quality metrics.
RxView determines who should receive which available intervention (or combinations of interventions) and tracks how well each intervention improves health care outcomes.
Lowering Cost of Adherence
For one large health plan serving over 1 million Medicare beneficiaries, RxAnte assigned patients to interventions based on patients’ future risk of suboptimal medication outcomes. This reduced the marginal cost to “create” a newly adherent patient by over 60% after only six months. The client achieved much better results out of its existing intervention investments. It used a more efficient program to invest in even more effective interventions, leading to larger population-level adherence improvements. Today, this health plan client is one of the fastest-improving plans on key medication quality measures in the nation.
RxEffect equips physician practices and community pharmacies with the information, tools, and incentives they need to more effectively manage the medication performance of patients whose risk profiles indicate that engagement by health professionals is necessary to achieve better outcomes.
Engaging Health Care Providers
Launched in July 2013 with a large national health plan operating in the Medicare Advantage progarm, RxEffect was rapidly adopted by almost 5,000 prescribers across over 500 physician practices within 8 weeks. After only three months, the patients whose physician practices used RxEffect regularly to manage performance on medication quality measures were significantly more likely to take their medications correctly and consistently compared to patients whose practices are not using the tool, even adjusting for baseline differences between participating and non-participating physician practices.